IRMD
IRADIMED CORP
Key Financials
Net Income
$22.5M
↑ 16.9%
Operating Income
$26.1M
↑ 19.0%
Revenue
$83.8M
↑ 14.4%
Gross Profit
$64.3M
↑ 14.2%
Shareholders' Equity
$94.6M
↑ 9.0%
Total Liabilities
$14.2M
↑ 23.0%
EPS (Diluted)
$1.75
↑ 16.7%
Cash & Equivalents
$51.2M
↓ 2.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/14/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 4 | 5/6/2026 | View on SEC |
| 10-Q | 5/1/2026 | View on SEC |
| 8-K | 5/1/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
| 4 | 4/30/2026 | View on SEC |
| 4 | 4/22/2026 | View on SEC |
| 4 | 4/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IRMD |
| Company Name | IRADIMED CORP |
| CIK | 1325618 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4076778022 |